The article titled Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis by Bighelli, et al, from the Boston Medical Center of Psychiatry published on December of 2018. This study wanted to introduce the first meta-analysis inquiring the effectiveness of using cognitive behavior therapy (CBT) on patients with schizophrenia. The results revealed that about 44.5% and 13.2% of patient accomplished about 20% and 50% reduction of symptoms. This means that cognitive behavioral therapy along with pharmacotherapy provides a “minimal improvement in overall symptoms”. This study is very valuable in proving that we should not waste our limited resources on implementing CBT to patient’s treatment plan.
This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.
